Value-Based Gap Analysis of Neuromonitoring

<p>Featuring: F. Todd Wetzel, MD, John Ney, MD, Tara Stewart, PhD, DABNM</p> <p><br></p> <p><br></p> <p>Disclosures:</p> <p>Wetzel, F. Todd: Stock Ownership: Relievant Medical (1%).&nbsp;</p> <p>Ney, John: Board of Directors: American Society for Neuromonitoring (None); Consulting: Ceribell (B), SpecialtyCare (B); Other Office: American Academy of Neurology, Medical Economics and Management Committee (Travel Expense Reimbursement); Speaking and/or Teaching Arrangements: SpecialtyCare (Travel Expense Reimbursement).&nbsp;</p> <p>Stewart, Tara: Private Investments: IONM Life LLC (Future Compensation Expected, Paid directly to institution/employer)</p> <p>Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+</p>